Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text: GLP-1s have only been approved for a few conditions, including obesity and diabetes.
Simplified Text: GLP-1 drugs are approved only for conditions such as obesity and diabetes.
Confidence Score: 1.000
Claim Maker: The New York Times
Context Type: News Article
Context Details: { "date": "2026-09-22", "approved_conditions": "obesity and diabetes" }
Subject Tags: GLP-1 Drug Approval Medical Conditions
UUID: 1e58a6e8-7770-439f-bcaf-bfde6f285ca5
Vector Index: ✗ No vector
Created: September 25, 2026 at 10:06 AM (2 weeks ago)
Last Updated: September 25, 2026 at 10:06 AM (2 weeks ago)

Original Sources for this Claim (2)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html

GLP-1 Prescriptions for People With No Medical Need Are Climbing

Completed News

7 claims

2 weeks ago

https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html

A new study analyzing over 92 million U.S. adult medical records found more than 1.1 million people taking GLP-1 medications without an apparent medical reason like obesity or diabetes. Doctors express concern over off-label use, potential risks, and the cultural phenomenon surrounding these drugs.

GLP-1 drugs Ozempic Off-label prescriptions Weight loss drugs Medical ethics Public health Obesity Diabetes

Screenshot of https://reason.com/2026/09/19/7-cool-advances-in-biosciences

Cancer Vaccines, Anti-Aging Treatments, and 5 Other Exciting Biomedical Advances

Completed Analysis

16 claims 🔥

1 week ago

https://reason.com/2026/09/19/7-cool-advances-in-biosciences

This article explores seven significant advancements in biosciences, including new diabetes and weight loss medications, treatments for high Lp(a), infectious disease vaccines, genome sequencing, cancer vaccines, human reproduction breakthroughs, and anti-aging therapies. It emphasizes the rapid progress in molecular biology.

Biosciences Biomedical Advances Cancer Vaccines Anti-Aging Diabetes Obesity Genetics Vaccines

Similar Claims (5)

Other claims identified as semantically similar to this one.

Off-label prescriptions for GLP-1s became far more common as the study went on, jumping 15-fold between 2021 and 2025. 1.000

Simplified: Off-label prescriptions for GLP-1 drugs increased 15-fold between 2021 and 2025.

2 weeks ago
These medications might pose unique risks to people who are not overweight, including malnutrition, as well as muscle mass loss, side effects of the drug that can affect anyone but that could be espec... 1.000

Simplified: GLP-1 medications may pose unique risks, such as malnutrition and muscle mass loss, for individuals who are not overweight, especially those with lowe...

2 weeks ago
The obesity rate for adults has begun declining largely due to the advent of GLP-1 medications. 0.800

Simplified: The obesity rate for adults has begun declining largely due to GLP-1 medications.

1 week ago
Dr. Andrew Kraftson, a clinical professor at the University of Michigan Medical School who treats patients with obesity, noted that the new study also highlight how many doctors seem to be prescribing... 1.000

Simplified: Dr. Andrew Kraftson, a clinical professor at the University of Michigan Medical School, noted that the new study highlights many doctors prescribing G...

2 weeks ago
Dr. Nils Krüger, a researcher at Harvard Medical School who has studied GLP-1s, said that it is the first time he can recall that the general public knows so much about a drug. 1.000

Simplified: Dr. Nils Krüger, a Harvard Medical School researcher who studied GLP-1s, stated that it is the first time he can recall the general public knowing so...

2 weeks ago